Drug profile · INN
olezarsen sodium
TRYNGOLZA (AUTOINJECTOR)
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
olezarsen sodium (TRYNGOLZA (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Associated with IONIS PHARMACEUTICALS INC. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is olezarsen sodium?
olezarsen sodium (TRYNGOLZA (AUTOINJECTOR)) is an FDA-listed pharmaceutical active ingredient. Associated with IONIS PHARMACEUTICALS INC. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for olezarsen sodium?
TRYNGOLZA (AUTOINJECTOR) is a marketed brand name for olezarsen sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of olezarsen sodium?
olezarsen sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.